India may ban the widely used antacid ranitidine as an expert panel submits a report highlighting cancer risks and NDMA ...

The update includes Pfizer Inc.’s (NYSE:PFE) Abrysvo (Respiratory Syncyt The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE ... British ...

MANILA, Philippines — GSK plc (LSE/NYSE: GSK ... Editor’s Note: This press release is sponsored by GlaxoSmithKline Philippines. It is published by the Advertising Content Team that is ...

This expands the previous authorization for individuals aged 60 and older, and ABRYSVO now of ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc. a global biopharma company to unite science technology and talent to get ahead of disease together. The Company is ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.